No red flag in India but a period of extended low returns, or a pullback likely: Vikash Kumar Jain

September 6, 2024

Vikash Kumar Jain from CLSA discusses India’s bullish market trends, potential for low returns, and the recent growth in the pharma sector. He highlights the need not to view global sectors through the India lens and says that will be a blatant mistake. Jain expects increased investment flows into India only after there is rising confidence in emerging markets.

More To Explore

Dr. Reddy’s Laboratories Q1 Results: PAT rises 2% YoY to Rs 1,418 crore, revenue jumps 11%

Dr Reddy’s Laboratories Q1 Results: Pharma major Dr. Reddy’s Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1,418

July 23, 2025

Tata Teleservices Q1 Results: Net loss rises marginally by 0.5% YoY, revenue down by 12%

Tata Teleservices (Maharashtra) posted a net loss of ₹324.98 crore in Q1FY26, with a 12.3% drop in revenue. While expenses fell and margins improved, weak

July 23, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003